Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell Model.
Ieva PalubeckaitėSanne VennekerBrendy E W M van den AkkerInge H Briaire-de BruijnJudith V M G BovéePublished in: Clinical orthopaedics and related research (2022)
Combination treatment of talazoparib and temozolomide was effective in reducing the viability of chondrosarcoma spheroids and spheroid growth, regardless of IDH mutation status, providing rationale to replicate this treatment combination in an animal chondrosarcoma model.